Skip to content
NKCELLThe NK guide

The biology

What Activates an NK Cell?

Target-cell contact and cytokine signalling both get called NK-cell activation, yet they are measured with different assays and support different conclusions.

An NK cell is activated when signals at its surface push it into action — but in research, "activation" names at least two different measurements. In a widely used flow-cytometry assay, human NK cells are mixed with target cells such as the K562 line and then checked for CD107a, a protein that appears on the cell surface when cytotoxic granules fuse with the plasma membrane. In other experiments, the readout is what the NK cell does in response to cytokines — small proteins that carry messages between cells. Both results get called activation. They answer different questions: one asks whether a receptor encounter triggered release, the other asks how the cell responds to a soluble signal. The authors of a flow-cytometry methods paper describing the CD107a approach are explicit about the limit: degranulation is not the same as target-cell lysis.

NK cells are lymphocytes of the innate immune system: they patrol for cells that look abnormal or infected. Flow cytometry, the technique behind the CD107a readout, passes single cells through a laser and measures fluorescent markers on each one, so a researcher can ask what fraction of cells shows a given protein at the surface.

Contact-driven triggering: what degranulation measures

When an NK cell touches a target, receptors on its membrane engage ligands on the other cell. In the methods paper, K562 cells supply that target-cell stimulus and CD107a supplies the readout. CD107a, also known as LAMP-1, normally lines the membranes of cytotoxic granules — the packets that hold the cell's killing proteins. When a granule fuses with the plasma membrane to release its contents, CD107a is left facing outward, where an antibody can find it.

What that readout captures is a fusion event. It is not a count of dead targets. A cell can degranulate while the target survives, because killing depends on what the granules deliver, how susceptible the target is, and other factors. A reasonable inference — one the methods authors support with their caution rather than a separate experiment in the paper — is that CD107a is best read as evidence that triggering occurred, not as proof of target-cell death.

Cytokine signals: a second route to the same word

Cytokines are secreted proteins that let cells influence one another; interleukin-15 (IL-15) is one that acts on NK cells. The same flow-cytometry paper pairs target-cell stimulation with cytokine readouts, measuring what the NK cells themselves produce alongside the degranulation marker. That pairing is useful precisely because the outputs are not interchangeable: a receptor-triggered granule fusion and a cytokine response tell you about different parts of the cell's behaviour, even when both are collected in one tube.

Where receptor and cytokine signals meet

A study of human NK cells reported that engagement of NKG2D — an activating receptor on the NK-cell surface — by its ligands MICA or ULBP2 triggered a nanoscale reorganization of the IL-15 receptor, and that this happened in a ligand-dependent manner. Nanoscale here means the scale of molecular clusters, smaller than a conventional microscope image resolves. In plain terms: when NKG2D was engaged, the arrangement of the IL-15 receptor in the membrane changed, and the change depended on the ligand being present.

That is a mechanistic result from cultured cells. One reading — an interpretation, not a claim the study makes about patients — is that receptor triggering and cytokine sensing are not fully separate tracks: what an NK cell contacts can shape how it handles a cytokine signal. The work does not establish any clinical effect, and in vitro findings of this kind should not be read as evidence of benefit in people.

Two readouts, two different claims

Swipe or scroll to read the full table →

Contact-driven triggering Cytokine signalling
What is present A target cell, for example K562 in the cited assay Cytokines such as IL-15
Example readout CD107a at the cell surface Cytokine production by the NK cell
What the readout shows A granule membrane fused with the plasma membrane The cell responded to a soluble signal
What the readout does not show That the target cell died That the cell can kill a target

The comparison is a general one about what each kind of measurement supports; the assay details come from the flow-cytometry methods paper, and the IL-15 point from the NKG2D study.

What a single result does not establish

  • Degranulation is not lysis. The methods authors state this directly; CD107a marks granule fusion, not target death.
  • Cytokine output is not killing capacity. A cell that secretes more of a cytokine has not thereby been shown to kill more targets.
  • Receptor reorganization is not a clinical result. The NKG2D and IL-15 receptor finding comes from human NK cells in culture, so it describes a mechanism, not an outcome in patients.
  • A population average is not a single cell's behaviour. Flow cytometry reports the fraction of cells above a threshold; two cells with the same marker can have arrived there by different routes.

Questions worth asking of the next NK-cell claim

When a study or a headline says NK cells were activated, four questions sort out what was actually shown. What was the stimulus — a target cell, a cytokine, or something else? What was measured — a surface marker, a secreted protein, or target-cell death? Was killing measured separately, or only inferred from a marker? And were the cells in culture, in an animal, or in people?

The word "activation" is shorthand. The informative question is always which signal went in and which output came out. Distinguishing contact-driven triggering from cytokine signalling is the quickest way to keep those two answers apart.

This is general educational information about immunology research and is not medical advice.

Sources and further reading

Keep reading

Follow the next question.

The biology